Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against ...
Mar 10, 2025
0
41
The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a study conducted by the Karl Landsteiner University of Health Sciences (KL Krems) and published ...
Mar 5, 2025
0
0
Some popular synthetic hair products used for braids, twists and extensions may contain cancer-causing chemicals and high levels of lead, according to a new investigation by Consumer Reports.
Mar 5, 2025
0
0
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of ...
Mar 3, 2025
0
48
Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable ...
Feb 27, 2025
0
18
A study led by the Joe C. Wen School of Population & Public Health at the University of California, Irvine has revealed possible links between exposure to per- and polyfluoroalkyl substances in drinking water and an increased ...
Feb 26, 2025
0
0
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have relapsed after allogenic ...
Jan 24, 2025
0
3
Various forms of blood cancer exist—all of which are grouped together under the term leukemia. One common form of leukemia is acute myeloid leukemia (AML), characterized by a degradation of early blood cell precursors, ...
Dec 18, 2024
0
2
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after a median follow-up of 6.1 years, ...
Dec 11, 2024
0
0
Patients with acute myeloid leukemia who have lower education levels and lower income are less likely to receive an allogeneic hematopoietic stem cell transplant for acute myeloid. However, if they can access the treatment, ...
Dec 9, 2024
0
0
